Showing 1,481 - 1,500 results of 19,603 for search '(( significant ((co decrease) OR (a decrease)) ) OR ( significant increase decrease ))', query time: 0.75s Refine Results
  1. 1481
  2. 1482
  3. 1483
  4. 1484
  5. 1485

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  6. 1486

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  7. 1487

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  8. 1488

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  9. 1489

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  10. 1490

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  11. 1491
  12. 1492
  13. 1493
  14. 1494
  15. 1495
  16. 1496
  17. 1497
  18. 1498

    Data Sheet 1_Eupalinolide A inhibits cancer progression and induces ferroptosis and apoptosis by targeting the AMPK/mTOR/SCD1 signalling in non-small cell lung cancer.docx by Yonghui Zhang (279832)

    Published 2025
    “…EA treatment (25 mg/kg) markedly inhibited tumour growth in vivo in a xenograft model; both tumour weight and tumour volume decreased by more than 60% without significantly affecting the body weight of tumour-bearing mice.…”
  19. 1499
  20. 1500